cancer
12 stories tagged "cancer"
The Same Cancer Mutation, Opposite Effects: What 581 Mouse Tumors Say About Who Gets Sick
Cambridge and Yale gave four strains of mice one identical dose of a carcinogen. The tumors converged on the same pathway but took four different genetic routes to get there, and today's screening ignores the reason.
InvestigationsBPA Sits in 90% of Us. The Cancer Studies Sample It With a Method That Was Never Going to Find Anything.
Bisphenol A shows up in more than nine of ten Americans, yet California's reviewers just called the cancer evidence 'inadequate,' because the studies measure a chemical the body clears in hours from a single urine sample.
CancerThe Evolutionary Fix for Drug Resistance Works Best on a Tumor Too Small to Find
City St George's mathematicians say hitting a tumor at its weakest moment can drive it extinct. Their own model clears 95 percent only below 7 million cells, far smaller than any tumor a scan can find.
CancerPregnancy Stations Killer T Cells in the Milk Ducts, and a Decade Later They Haven't Left
Melbourne researchers found that pregnancy stations killer T cells in the milk ducts, where they persist for at least a decade and track with better breast cancer outcomes. Now the race is on to summon them with a hormone shot instead of a pregnancy.
CancerWhether a T Cell Keeps Killing Cancer or Quits Is Written in How Its Genome Folds
Exhausted CD8 T cells are why checkpoint drugs and CAR-T so often stall. New maps of the 3D genome show their fate is set by how the DNA is physically folded, and by CTCF, the protein that does the folding.
CancerOne Protein Keeps Your T Cells in the Fight. The Same Protein Feeds Autoimmune Disease.
In mice, deleting the LEF1 gene collapsed the reserve T cells that sustain the fight against chronic infection and cancer. The same deletion protected against autoimmune diabetes.
CancerA Repair Gene Turns Saboteur, and a $4 Billion Drug Class Sees an Opening
A Penn State lab found that too much of the DNA repair gene EXO1 makes ordinary tumors behave like BRCA-mutant ones in a dish, and respond to the same drugs. The science is clean. The market context is not.
InvestigationsA Top Cancer Scientist, a Deleted Study, and the Question Washington Won't Fund
A June 2026 Senate subcommittee hearing centered on a Brown University cancer researcher's review of 333 post-vaccination cancer case reports, and on the retractions, censorship, and cyberattack that met it.
CancerIvermectin and Cancer: The Review the Horse-Paste Crowd Wasn't Supposed to Get
A 2025 systematic review finds coherent anticancer biology in ivermectin across ten tumor types. The human evidence to match it does not exist. The question of why is what the punchline was designed to bury.
CancerA Korean lab found cancer's DNA-repair off-switch. In a mouse.
A Korean state lab reports that a tool compound called UNI418 strips out the DNA-repair proteins cancer cells use to escape PARP inhibitors. The data are preclinical: cell lines and mouse xenografts. UNI418 is not yet a drug.
InvestigationsA Senate Subcommittee Just Put the COVID Shot Cancer Question on the Record
A Senate Homeland Security subcommittee took testimony on whether mRNA COVID shots can plausibly cause cancer, and on the parallel campaign to keep that question out of the journals. Dr. John Campbell walked his audience through it.
InvestigationsA Senate hearing finally put the cancer question on the record. The journal notice had been up for months.
Sen. Ron Johnson's June 3 subcommittee hearing on plausible mechanisms linking mRNA injections to cancer, the South Korean cohort behind it, and the editorial notice Springer had posted on the paper months earlier.